Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Atrial fibrillation

Recruiting

Investigational

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational

Slovakia

Participants:65+ years
Substances:Abelacimab

Contact Research Centre

Tardive dyskinesia

Recruiting

Investigational

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Investigational

Slovakia

Participants:18–64 years · 65+ years

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Major depression

Recruiting

InvestigationalNo placebo

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Major depression

Recruiting

Investigational

Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Schizophrenia

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Slovakia

Participants:18–64 years
Substances:Iclepertin

Contact Research Centre

Obesity

Not recruiting

InvestigationalNo placebo

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Cagrilintide

Contact Research Centre

Type 2 diabetes mellitus+1

Not recruiting

Registered drugNo placebo

Study comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Insulin Glargine

Contact Research Centre

Major depression

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Aticaprant

Contact Research Centre

Schizophrenia

Not recruiting

Investigational

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Valbenazine Ditosylate

Contact Research Centre

Schizophrenia

Not recruiting

Investigational

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Valbenazine Ditosylate

Contact Research Centre

Find therapies in clinical trials near you

11 trials match your criteria

Atrial fibrillation

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Tardive dyskinesia

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Type 2 diabetes mellitus

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Major depression

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

Major depression

Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

Schizophrenia

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Obesity

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Type 2 diabetes mellitus+1

Study comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone

Major depression

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

Schizophrenia

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Schizophrenia

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.